Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-07-24 |
2024-06 |
0.66 |
N/A |
N/A |
N/A |
2024-05-06 |
2024-03 |
0.55 |
0.55 |
N/A |
N/A |
2024-02-28 |
2023-12 |
0.9 |
0.89 |
-0.01 |
-1.11% |
2023-10-25 |
2023-09 |
0.78 |
0.76 |
-0.02 |
-2.56% |
2023-07-26 |
2023-06 |
0.57 |
0.71 |
0.14 |
24.56% |
2023-04-26 |
2023-03 |
0.74 |
0.74 |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2023-08-23 |
Morgan Stanley |
Downgrade |
Equal-Weight |
Underweight |
2023-07-27 |
JMP Securities |
Upgrade |
Outperform |
Outperform |
2023-07-18 |
Truist Securities |
Upgrade |
Hold |
Hold |
2023-07-11 |
Jefferies |
Upgrade |
Hold |
Buy |
2023-06-07 |
Argus Research |
Downgrade |
Buy |
Hold |
2023-05-30 |
Morgan Stanley |
Upgrade |
Equal-Weight |
Equal-Weight |
Date |
Name |
Relation |
Quantity |
Description |
2024-05-08 |
BRADLEY KEITH |
Director |
69.94K |
Stock Award(Grant) |
2024-05-08 |
CLAY SHAUNDRA |
Director |
21.92K |
Stock Award(Grant) |
2024-03-10 |
DAVIS ROBERT T JR |
Officer |
65.11K |
Stock Award(Grant) |
2024-05-22 |
ESSIG STUART M |
Chairman of the Board |
1.75M |
Purchase |
2024-05-08 |
GRAVES JEFFREY A. |
Director |
12.49K |
Stock Award(Grant) |
2024-05-20 |
HILL BARBARA BENTON |
Director |
0.00 |
Purchase |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Group Inc |
7.09M |
291.51M |
8.71% |
2023-06-29 |
Blackrock Inc. |
6.78M |
278.67M |
8.32% |
2023-06-29 |
Morgan Stanley |
6.26M |
257.31M |
7.69% |
2023-06-29 |
Champlain Investment Partners, LLC |
3.90M |
160.48M |
4.79% |
2023-06-29 |
Wellington Management Group, LLP |
3.36M |
138.10M |
4.13% |
2023-06-29 |
Capital Research Global Investors |
3.26M |
134.01M |
4.00% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Smallcap World Fund |
2.87M |
118.14M |
3.53% |
2023-09-29 |
iShares Core S&P Midcap ETF |
2.21M |
84.59M |
2.72% |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
2.17M |
89.06M |
2.66% |
2023-06-29 |
Vanguard Small-Cap Index Fund |
1.80M |
73.93M |
2.21% |
2023-07-30 |
Legg Mason Clearbridge Small Cap Growth Fd |
1.62M |
73.83M |
1.99% |
2023-05-30 |
Delaware Group Equity Funds V-Small Cap Value Fund |
1.18M |
44.71M |
1.45% |
Split |
Date |
2 : 1 |
2017-01-04 |
1106 : 1000 |
2015-07-01 |
0.5 : 1 |
1998-05-26 |